Diagnos Inc (ADK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Diagnos Inc (ADK) has a cash flow conversion efficiency ratio of 0.539x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-828.10K ≈ $-599.04K USD) by net assets (CA$-1.54 Million ≈ $-1.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ADK equity financing ratio to measure how much of total assets are equity-financed.
Diagnos Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Diagnos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ADK cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Diagnos Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnos Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orcay Ortakoy Cay Sanayi & Ticaret AS
IS:ORCAY
|
0.063x |
|
MDI Energia S.A.
WAR:MDI
|
1.692x |
|
Castile Resources Ltd
AU:CST
|
-0.018x |
|
BIOCERES CROP SOL.
F:0G4
|
0.163x |
|
Kintech Electronics Co Ltd
TWO:6210
|
-0.107x |
|
Jeong Moon Information. Co. Ltd
KQ:033050
|
0.059x |
|
Nortech Systems Incorporated
NASDAQ:NSYS
|
-0.003x |
|
African Media Entertainment
JSE:AME
|
0.070x |
Annual Cash Flow Conversion Efficiency for Diagnos Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Diagnos Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | CA$233.11K ≈ $168.63K |
CA$-3.64 Million ≈ $-2.63 Million |
-15.604x | -2076.03% |
| 2024-03-31 | CA$-3.05 Million ≈ $-2.21 Million |
CA$-2.41 Million ≈ $-1.74 Million |
0.790x | -18.33% |
| 2023-03-31 | CA$-1.95 Million ≈ $-1.41 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.967x | -94.61% |
| 2022-03-31 | CA$-113.51K ≈ $-82.11K |
CA$-2.04 Million ≈ $-1.47 Million |
17.954x | +1598.12% |
| 2021-03-31 | CA$1.13 Million ≈ $818.98K |
CA$-1.36 Million ≈ $-981.49K |
-1.198x | +17.44% |
| 2020-03-31 | CA$1.82 Million ≈ $1.32 Million |
CA$-2.64 Million ≈ $-1.91 Million |
-1.452x | -418.05% |
| 2019-03-31 | CA$-5.08 Million ≈ $-3.68 Million |
CA$-2.32 Million ≈ $-1.68 Million |
0.456x | -26.02% |
| 2018-03-31 | CA$-3.64 Million ≈ $-2.63 Million |
CA$-2.24 Million ≈ $-1.62 Million |
0.617x | +92.48% |
| 2017-03-31 | CA$-5.58 Million ≈ $-4.03 Million |
CA$-1.79 Million ≈ $-1.29 Million |
0.321x | -54.80% |
| 2016-03-31 | CA$-3.15 Million ≈ $-2.28 Million |
CA$-2.23 Million ≈ $-1.62 Million |
0.709x | -94.44% |
| 2015-03-31 | CA$-224.85K ≈ $-162.65K |
CA$-2.87 Million ≈ $-2.07 Million |
12.748x | +464.40% |
| 2014-03-31 | CA$346.95K ≈ $250.98K |
CA$-1.21 Million ≈ $-878.01K |
-3.498x | -204.12% |
| 2013-03-31 | CA$1.75 Million ≈ $1.26 Million |
CA$-2.01 Million ≈ $-1.45 Million |
-1.150x | -41.39% |
| 2012-03-31 | CA$2.34 Million ≈ $1.70 Million |
CA$-1.91 Million ≈ $-1.38 Million |
-0.814x | +31.73% |
| 2011-03-31 | CA$1.18 Million ≈ $855.17K |
CA$-1.41 Million ≈ $-1.02 Million |
-1.192x | -56.73% |
| 2010-03-31 | CA$1.98 Million ≈ $1.43 Million |
CA$-1.51 Million ≈ $-1.09 Million |
-0.760x | -4.87% |
| 2009-03-31 | CA$2.41 Million ≈ $1.74 Million |
CA$-1.75 Million ≈ $-1.26 Million |
-0.725x | -557420.15% |
| 2008-03-31 | CA$4.21 Million ≈ $3.04 Million |
CA$-547.00 ≈ $-395.69 |
0.000x | +99.98% |
| 2007-03-31 | CA$1.42 Million ≈ $1.03 Million |
CA$-876.30K ≈ $-633.90K |
-0.616x | +60.42% |
| 2006-03-31 | CA$793.68K ≈ $574.14K |
CA$-1.24 Million ≈ $-894.18K |
-1.557x | +86.16% |
| 2005-03-31 | CA$161.61K ≈ $116.91K |
CA$-1.82 Million ≈ $-1.32 Million |
-11.252x | -1503.98% |
| 2004-03-31 | CA$-128.75K ≈ $-93.14K |
CA$-103.19K ≈ $-74.64K |
0.801x | -73.66% |
| 2003-03-31 | CA$-264.64K ≈ $-191.44K |
CA$-805.06K ≈ $-582.37K |
3.042x | -56.40% |
| 2002-03-31 | CA$-325.75K ≈ $-235.64K |
CA$-2.27 Million ≈ $-1.64 Million |
6.978x | -- |
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more